News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
HUTCHMED to Disclose Several Research Data at AACR Annual Meeting
The new and updated data from several studies of compounds discovered by HUTCHMED (00013.HK) will be presented at the upcoming American Association of Cancer Research (AACR) Annual...
Reset
Send
The window will close in 5 seconds
HUTCHMED to Disclose Several Research Data at AACR Annual Meeting
Close
Recommend
4
Positive
10
Negative
8
 
SHORT SELL
 
STOCK INFO

The new and updated data from several studies of compounds discovered by HUTCHMED (00013.HK)  -0.150 (-0.513%)    Short selling $11.69M; Ratio 10.197%   will be presented at the upcoming American Association of Cancer Research (AACR) Annual Meeting 2024, taking place on 5-10 April 2024 in San Diego, California, according to HUTCHMED's announcement.

Of which, initial preclinical data will be presented for HMPL-506, a novel, highly potent and differentiated menin-MLL inhibitor for the treatment of certain types of acute leukemia.

The investigational drug candidate displayed favorable pharmacokinetic profiles, high selectivity and low risk of cardiac toxicity. A Phase I study of HMPL-506 is planned for 2H24.
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2024-11-06 16:25.)

AAStocks Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.